KIMMTRAK
Google image searchProduct monograph
Active ingredient
tebentafusp, 100 MCG/0.5 ML
DIN: 02527588
Dosage form(s): SOLUTION
Route(s) of administration: INTRAVENOUS
Description: SINGLE USE
Schedule: Prescription / Schedule D
Company: IMMUNOCORE IRELAND LIMITED
Date: 23-AUG-2022
ATC:
- L01 — ANTINEOPLASTIC AGENTS (ATC, ATC/DDD, )
- L01X — OTHER ANTINEOPLASTIC AGENTS (ATC, ATC/DDD)
- L01XX — Other antineoplastic agents (ATC, ATC/DDD)
- L01XX75 — TEBENTAFUSP (ATC/DDD)
